[Diagnosis and treatment of episcleritis and scleritis].

Tappeiner, Christoph; Walscheid, K; Heiligenhaus, A (2016). [Diagnosis and treatment of episcleritis and scleritis]. Der Ophthalmologe, 113(9), pp. 797-810. Springer 10.1007/s00347-016-0344-3

Preview

Text s00347-016-0344-3.pdf - Published Version Available under License Publisher holds Copyright. Download (1MB) | Preview

Episcleritis is a benign and self-limiting disease, often with a recurrent course, manifesting mainly in young adults. In less than a third of patients, an associated systemic disease can be found. In contrast, scleritis is observed mainly in patients between the 4th and 6th decade of life, may lead to severe ocular complications, and is often associated with a systemic rheumatological disease. Diffuse, nodular, and necrotizing forms of scleritis can be differentiated. Necrotizing and posterior scleritis have a higher risk of complications and worse visual outcome. In most cases, medical history and slit lamp examination allow differentiation of episcleritis and scleritis. Whereas episcleritis is treated mainly symptomatically with artificial tears, topical corticosteroids, and potentially with systemic nonsteroidal anti-inflammatory drugs, scleritis requires early and aggressive anti-inflammatory treatment in a stepwise approach.

Interest & Impact

Downloads

128 since deposited on 18 Apr 2019
128 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item